BOCA RATON, Fla.--(BUSINESS WIRE)--Juniper Group (JUNP:OB) announced today that management personnel from its wholly-owned telecommunications subsidiary have successfully completed a client-required orientation program in the Mid-Atlantic market, where new project work is expected to begin after the holiday weekend.
Vlado P. Hreljanovic, President and CEO said, “We are looking forward to working with this prestigious client, whose fiber optic network currently passed over 15 million premises, and who services nearly 93 million customers nationwide. It is very exciting to be involved in the development of new products, services and applications for next generation technologies. We strive to consistently keep our managers and technical crews abreast of the learning curve for cutting edge advanced communications data and industry growth.”
Safe Harbor
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The forward-looking statements are based on current expectations, estimates and projections made by management. The Company intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. The forward-looking statements contained in this press release include, statements regarding client orientation and beginning new project work. All forward-looking statements in this press release are made as of the date of this press release, and Juniper assumes no obligation to update these forward-looking statements other than as required by law. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements and include the risk that the work may not commence after the holiday weekend and our growth will not continue as anticipated and the factors discussed in the Business and Management’s Discussion and Analysis sections in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Copies of these filings are available at www.sec.gov.
Wednesday, June 30, 2010
Monday, June 28, 2010
Proper Power & Energy Announces First Data Analysis From Seismics
TAMPA, Fla., June 28 /PRNewswire-FirstCall/ -- Proper Power & Energy, Inc. (OTC Bulletin Board:PPWE.ob - News) announced today the Company released the first data analysis report of its Central Utah prospect as compiled by Thrust Resources geophysicist Robert Dunbar. The Company retained Thrust Resources' compiled Radiometrics Plus survey when it purchased its lease in the Rush Valley in late 2007. This past summer, the Company purchased independent, reprocessed seismic data on the same fields to compare those readings with the Radiometrics Plus. Radiometrics measures radioactive hydrocarbons as they migrate upward through the Earth's underground. Seismic data is based on traditional geological measurement of sound waves through the Earth's crust.
Based on his initial review of the seismic, Mr. Dunbar believes that the previous reserve projections may have been severely understated. "In comparing the Rush Valley Prospect to Covenent Field, a thicker Mississippian shale source bed should be present, since the Mississippian shale thickens westward from approximately 1000 feet at Covenent to 7000 feet in Central Nevada. Vertical migration of hydrocarbon from the Mississippian is believed to be the reason for the Navaho accumulation at Covenent. Also the Navaho section at Rush Valley should be thicker and is expected to be approximately 1500 feet. Therefore, the 10 to 15 million barrels of oil reserve per well on 80 acre spacing at Covenent may be quite conservative when applied to Rush Valley," stated Robert Dunbar. "Depths may be roughly calculated by applying a factor or 7 times the seismic time in milliseconds. Example – one second or a time of 1000 milliseconds times 7 equals 7000 feet."
The "Covenant Field" prospect that Mr. Dunbar points to in his comparison refers to the Central Utah prospect developed by Wolverine Oil commencing in 2006. That prospect is producing an estimated 12,000 barrels of crude daily in Sevier County, Utah. The Company plans to release follow-ups to Mr. Dunbar's analysis of the seismic data, and has already released independent seismic reports and recent testimonials from independent sources concerning Thrust Resources' success rate in accurately predicting reserves, or just as importantly, the lack of reserves on prospects throughout the contiguous geographic area.
"We are happy to report that after weighing in with this new seismic data, our Utah holdings may have been understated and our reserves could be substantially greater than anticipated," stated Proper Power & Energy President, Joseph E. Abdo, commenting on the seismic report.
About Proper Power & Energy:
Proper Power & Energy was formed in 2006 as an exploration and production company for oil and gas. The organization is committed to utilizing a very dynamic system of research and testing, and as a result of this extensive research and testing, have selected several sites with very good to excellent potential for productivity.
Safe Harbor Statement:
Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.
Based on his initial review of the seismic, Mr. Dunbar believes that the previous reserve projections may have been severely understated. "In comparing the Rush Valley Prospect to Covenent Field, a thicker Mississippian shale source bed should be present, since the Mississippian shale thickens westward from approximately 1000 feet at Covenent to 7000 feet in Central Nevada. Vertical migration of hydrocarbon from the Mississippian is believed to be the reason for the Navaho accumulation at Covenent. Also the Navaho section at Rush Valley should be thicker and is expected to be approximately 1500 feet. Therefore, the 10 to 15 million barrels of oil reserve per well on 80 acre spacing at Covenent may be quite conservative when applied to Rush Valley," stated Robert Dunbar. "Depths may be roughly calculated by applying a factor or 7 times the seismic time in milliseconds. Example – one second or a time of 1000 milliseconds times 7 equals 7000 feet."
The "Covenant Field" prospect that Mr. Dunbar points to in his comparison refers to the Central Utah prospect developed by Wolverine Oil commencing in 2006. That prospect is producing an estimated 12,000 barrels of crude daily in Sevier County, Utah. The Company plans to release follow-ups to Mr. Dunbar's analysis of the seismic data, and has already released independent seismic reports and recent testimonials from independent sources concerning Thrust Resources' success rate in accurately predicting reserves, or just as importantly, the lack of reserves on prospects throughout the contiguous geographic area.
"We are happy to report that after weighing in with this new seismic data, our Utah holdings may have been understated and our reserves could be substantially greater than anticipated," stated Proper Power & Energy President, Joseph E. Abdo, commenting on the seismic report.
About Proper Power & Energy:
Proper Power & Energy was formed in 2006 as an exploration and production company for oil and gas. The organization is committed to utilizing a very dynamic system of research and testing, and as a result of this extensive research and testing, have selected several sites with very good to excellent potential for productivity.
Safe Harbor Statement:
Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.
Proper Power Receives Additional Endorsements on Thrust Resources
TAMPA, Fla., June 25 /PRNewswire-FirstCall/ -- Proper Power & Energy, Inc. (OTC Bulletin Board:PPWE.ob - News) announced today receipt of additional letters of support for the RadioMetrics Plus (RMP) survey tool. The Company has based its petroleum reserve projections of its leased mineral rights on the RMP method and subsequent historic seismic data readings.
In a written statement from Red Fork Production, LLC of San Antonio, Texas, the statement reads, "I have known of Don Metcalfe and Robert Dunbar for almost 20 years.
"Who says the Wild-Catter is dead? A small company, with eight employees, out of Grand Rapids, Michigan, has just discovered a field in Central Utah, with over one billion barrels of recoverable oil. The company, Wolverine Oil and Gas, now sits atop a gigantic oil field, one of the largest in the Continental United States ... I will never forget that. But Mr. Dunbar and Mr. Metcalfe have many times in their careers been at the center of historic discoveries and their humble attitude and tireless persistence is an inspiration to all of us.
"On a smaller scale, Mr. Dunbar and Mr. Metcalfe have performed RadioMetrics Plus Surveys for our Company, as well. From 2005 – 2010, we have utilized RadioMetrics Plus technology in our operations in Texas and Oklahoma, and the effective rate has been measurably higher than the industry average. We have taken the raw numbers and derived excellent drill targets, and we have used the same technologies to eliminate areas of low/no potential."
"Clearly this statement represents more objective support for the RadioMetrics Plus data survey tool for hydrocarbons release," stated Proper Power & Energy President, Joseph Abdo. "Additionally, this case study continues to suggest that Thrust is the best outfit to conduct exploration in the state of Utah given their verifiable extensive activity and experience there," concluded Abdo.
About Proper Power & Energy:
Proper Power & Energy was formed in 2006 as an exploration and production company for oil and gas. The organization is committed to utilizing a very dynamic system of research and testing, and as a result of this extensive research and testing, have selected several sites with very good to excellent potential for productivity.
Safe Harbor Statement:
Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.
In a written statement from Red Fork Production, LLC of San Antonio, Texas, the statement reads, "I have known of Don Metcalfe and Robert Dunbar for almost 20 years.
"Who says the Wild-Catter is dead? A small company, with eight employees, out of Grand Rapids, Michigan, has just discovered a field in Central Utah, with over one billion barrels of recoverable oil. The company, Wolverine Oil and Gas, now sits atop a gigantic oil field, one of the largest in the Continental United States ... I will never forget that. But Mr. Dunbar and Mr. Metcalfe have many times in their careers been at the center of historic discoveries and their humble attitude and tireless persistence is an inspiration to all of us.
"On a smaller scale, Mr. Dunbar and Mr. Metcalfe have performed RadioMetrics Plus Surveys for our Company, as well. From 2005 – 2010, we have utilized RadioMetrics Plus technology in our operations in Texas and Oklahoma, and the effective rate has been measurably higher than the industry average. We have taken the raw numbers and derived excellent drill targets, and we have used the same technologies to eliminate areas of low/no potential."
"Clearly this statement represents more objective support for the RadioMetrics Plus data survey tool for hydrocarbons release," stated Proper Power & Energy President, Joseph Abdo. "Additionally, this case study continues to suggest that Thrust is the best outfit to conduct exploration in the state of Utah given their verifiable extensive activity and experience there," concluded Abdo.
About Proper Power & Energy:
Proper Power & Energy was formed in 2006 as an exploration and production company for oil and gas. The organization is committed to utilizing a very dynamic system of research and testing, and as a result of this extensive research and testing, have selected several sites with very good to excellent potential for productivity.
Safe Harbor Statement:
Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.
Thursday, June 24, 2010
Mammoth Energy Group Announces It Is in Final Discussions
Press Release Source: Mammoth Energy Group, Inc. On Tuesday May 18, 2010, 8:30 am EDT
NEW YORK, NY--(Marketwire - 05/18/10) - Mammoth Energy Group Inc. (Pinksheets:MMTE - News) announced today that it is in final discussions with Salt Gold Inter Chile Limitada, of Chile, regarding its Lithium concessions.
Salt Gold Inter Chile Limitada currently operates in the North West region of the country located in the heart of the Atacama Desert.
"We are moving along diligently and as quickly as possible," announced Mr. William Lieberman, President of Mammoth Energy Group.
About Mammoth Energy Group Inc. (Pinksheets:MMTE - News) http://www.mammothenergygroup.com/
Mammoth Energy Group Inc is focused on acquiring, developing and operating strategic mining energy reserves in locations throughout the world. With an ever changing shift to alternative energy and fuels Mammoth Energy Group will be prepared to be a leading energy supplier and operator. Mammoth Energy's goal is to become an important partner as the world's energy paradigm begins to change throughout the next decade and beyond.
Forward-Looking Statements
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities and Exchange Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, and such Forward-Looking Statements are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to the viability of the company's business plans, the effect of acquisitions on our profitability, the effectiveness, profitability, and the marketability of the Company's products; the Company's ability to protect its proprietary information; general economic and business conditions; the volatility of the company's operating results and financial condition; and other risks detailed in the Company's filings with the Securities and Exchange Commission.
These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about the company and the industry. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or to changes in its expectations, except as may be required by law. Although the company believes that the expectations expressed in these forward-looking statements are reasonable, management cannot assure the public that their expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results.
NEW YORK, NY--(Marketwire - 05/18/10) - Mammoth Energy Group Inc. (Pinksheets:MMTE - News) announced today that it is in final discussions with Salt Gold Inter Chile Limitada, of Chile, regarding its Lithium concessions.
Salt Gold Inter Chile Limitada currently operates in the North West region of the country located in the heart of the Atacama Desert.
"We are moving along diligently and as quickly as possible," announced Mr. William Lieberman, President of Mammoth Energy Group.
About Mammoth Energy Group Inc. (Pinksheets:MMTE - News) http://www.mammothenergygroup.com/
Mammoth Energy Group Inc is focused on acquiring, developing and operating strategic mining energy reserves in locations throughout the world. With an ever changing shift to alternative energy and fuels Mammoth Energy Group will be prepared to be a leading energy supplier and operator. Mammoth Energy's goal is to become an important partner as the world's energy paradigm begins to change throughout the next decade and beyond.
Forward-Looking Statements
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities and Exchange Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, and such Forward-Looking Statements are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to the viability of the company's business plans, the effect of acquisitions on our profitability, the effectiveness, profitability, and the marketability of the Company's products; the Company's ability to protect its proprietary information; general economic and business conditions; the volatility of the company's operating results and financial condition; and other risks detailed in the Company's filings with the Securities and Exchange Commission.
These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about the company and the industry. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or to changes in its expectations, except as may be required by law. Although the company believes that the expectations expressed in these forward-looking statements are reasonable, management cannot assure the public that their expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results.
Wednesday, June 23, 2010
Kalahari Greentech, Inc. Announces That Wind Power Grew 42% in 2008 Over 2007 and is Expected to Continue to Grow at 15.7% until 2013
FORT WALTON BEACH, Fla., June 23, 2010 (GLOBE NEWSWIRE) -- Kalahari Greentech, Inc. (Pink Sheets:KHGT - News) released a statement today that wind power is expected to continue to grow worldwide, in part due to favorable government policies. The U.S. Department of Energy has announced a goal of obtaining 6% of U.S. energy from wind by 2020. This goal is consistent with the current nationwide growth rate of wind power. (Source: http://www.awea.org/).
From 1990 -- 2002, wind has been the fastest-growing power source worldwide on a percentage basis, with an annual average growth rate exceeding 30%. An average U.S. household uses about 10,655 kilowatt-hours of electricity each year. One megawatt of wind energy can generate 2.4 to more than 3 million kilowatt-hours per year. (Source: http://www.awea.org/).
The 2009 World Wind Energy Report issued by the World Wind Energy Association illustrated impressive growth rates in the wind sector in 2009, despite the global financial crisis. The report states, "Increasing awareness of the economic, social and environmental benefits of wind energy will further boost investment in new wind farms." (Source: http://www.wwindea.org/).
According to a BTM Consult report posted on RenewableEnergyWorld.com, 2008 saw the highest ever level of wind turbine installations. The growth rate was 42% compared with 2007. The report's forecast also noted that the expected average annual growth rate expected through 2013 is 15.7% per year. More than 200 GW of new wind power capacity could emerge before the end of 2013 (Source: http://www.renewableenergyworld.com/).
Wind and solar are fast becoming the leading sources of renewable energy. Kalahari Greentech designs, produces and provides wind turbines, solar collectors and other sustainable energy technologies. Nearly $2 billion in money from the American Recovery and Reinvestment Act has been spent on wind power, funding the creation of enough new wind farms to power 2.4 million homes over the past year. (Source: http://www.abcnews.com/).
Kalahari's Wind Generator concentrates wind energy in a manner such that it can generate electric power at speeds usually too slow for conventional wind generators to produce any meaningful energy, or to even operate. It can also be modified to operate in water. For instance, it can be utilized in streams, rivers and tidal basins.
Many wind generators on the market today are a hazard to birds and other wildlife. Kalahari's Wind Generator avoids the bird strike problem because each unit comes standard with a shield that blocks birds from being hit by the turbine blades. The screen is sufficiently fine, such that not even a hummingbird can get through. The unit also releases short-range ultra-sonic waves that deter insects from nesting within the apparatus.
More information can be found on the company's website, http://www.kalaharigt.com/.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
From 1990 -- 2002, wind has been the fastest-growing power source worldwide on a percentage basis, with an annual average growth rate exceeding 30%. An average U.S. household uses about 10,655 kilowatt-hours of electricity each year. One megawatt of wind energy can generate 2.4 to more than 3 million kilowatt-hours per year. (Source: http://www.awea.org/).
The 2009 World Wind Energy Report issued by the World Wind Energy Association illustrated impressive growth rates in the wind sector in 2009, despite the global financial crisis. The report states, "Increasing awareness of the economic, social and environmental benefits of wind energy will further boost investment in new wind farms." (Source: http://www.wwindea.org/).
According to a BTM Consult report posted on RenewableEnergyWorld.com, 2008 saw the highest ever level of wind turbine installations. The growth rate was 42% compared with 2007. The report's forecast also noted that the expected average annual growth rate expected through 2013 is 15.7% per year. More than 200 GW of new wind power capacity could emerge before the end of 2013 (Source: http://www.renewableenergyworld.com/).
Wind and solar are fast becoming the leading sources of renewable energy. Kalahari Greentech designs, produces and provides wind turbines, solar collectors and other sustainable energy technologies. Nearly $2 billion in money from the American Recovery and Reinvestment Act has been spent on wind power, funding the creation of enough new wind farms to power 2.4 million homes over the past year. (Source: http://www.abcnews.com/).
Kalahari's Wind Generator concentrates wind energy in a manner such that it can generate electric power at speeds usually too slow for conventional wind generators to produce any meaningful energy, or to even operate. It can also be modified to operate in water. For instance, it can be utilized in streams, rivers and tidal basins.
Many wind generators on the market today are a hazard to birds and other wildlife. Kalahari's Wind Generator avoids the bird strike problem because each unit comes standard with a shield that blocks birds from being hit by the turbine blades. The screen is sufficiently fine, such that not even a hummingbird can get through. The unit also releases short-range ultra-sonic waves that deter insects from nesting within the apparatus.
More information can be found on the company's website, http://www.kalaharigt.com/.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
Monday, June 21, 2010
Kalahari Greentech, Inc. Details the Solar Collector
FORT WALTON BEACH, Fla., June 21, 2010 (GLOBE NEWSWIRE) -- Kalahari Greentech, Inc. (Pink Sheets:KHGT - News) released a statement today discussing its high-tech Solar Collector in detail.
Wind and solar are fast becoming the leading sources of renewable energy. Kalahari Greentech designs, produces and provides wind turbines, solar collectors and other sustainable energy technologies. Worldwide wind power generation exceeded 200 billion kilowatthours in 2008, which is equivalent to the annual electricity consumption of over 18 million average households in the United States. Wind generation increased by about 25% from 2007 to 2008, and has more than tripled since 2003. This growth is mostly due to capacity increases in the United States, China, India, and Western Europe (Source: http://www.eia.doe.gov).
According to the U.S. Department of Energy's news release dated March 25, 2009, entitled, "Solar Energy Grew at a Record Pace in 2008," solar energy deployment increased at a record pace in the United States and throughout the world in 2008. On March 19, 2009 the Solar Energy Industries Association (SEIA) released its "2008 U.S. Solar Industry Year in Review," which found that U.S. solar energy capacity increased by 17% the past year, reaching the equivalent of 8,775 megawatts (MW). The SEIA report also notes that the United States installed 342 MW of solar photovoltaic (PV) electric power, 139 thermal megawatts (MWTh) of solar water heating, 762 MWTh of pool heating, and 21 MWTh of solar space heating and cooling in 2008. (Source: http://www.energy.gov/).
Kalahari's Solar Collector addresses the matters of collector and system efficiency to build a single cost-effective unit. To do this, the collector operates three functions simultaneously to enhance system performance. Hence, it has been labeled as a "Tri-Brid" system. Without all three functions being performed from a single integrated system, the solar collector would not be economically viable. However, since the three functions do take place together, Kalahari's combination Thermal-Voltaic Solar Collector proves to be a cost-effective unit.
More information can be found on the company's website, http://www.kalaharigt.com/.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward-Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
Wind and solar are fast becoming the leading sources of renewable energy. Kalahari Greentech designs, produces and provides wind turbines, solar collectors and other sustainable energy technologies. Worldwide wind power generation exceeded 200 billion kilowatthours in 2008, which is equivalent to the annual electricity consumption of over 18 million average households in the United States. Wind generation increased by about 25% from 2007 to 2008, and has more than tripled since 2003. This growth is mostly due to capacity increases in the United States, China, India, and Western Europe (Source: http://www.eia.doe.gov).
According to the U.S. Department of Energy's news release dated March 25, 2009, entitled, "Solar Energy Grew at a Record Pace in 2008," solar energy deployment increased at a record pace in the United States and throughout the world in 2008. On March 19, 2009 the Solar Energy Industries Association (SEIA) released its "2008 U.S. Solar Industry Year in Review," which found that U.S. solar energy capacity increased by 17% the past year, reaching the equivalent of 8,775 megawatts (MW). The SEIA report also notes that the United States installed 342 MW of solar photovoltaic (PV) electric power, 139 thermal megawatts (MWTh) of solar water heating, 762 MWTh of pool heating, and 21 MWTh of solar space heating and cooling in 2008. (Source: http://www.energy.gov/).
Kalahari's Solar Collector addresses the matters of collector and system efficiency to build a single cost-effective unit. To do this, the collector operates three functions simultaneously to enhance system performance. Hence, it has been labeled as a "Tri-Brid" system. Without all three functions being performed from a single integrated system, the solar collector would not be economically viable. However, since the three functions do take place together, Kalahari's combination Thermal-Voltaic Solar Collector proves to be a cost-effective unit.
More information can be found on the company's website, http://www.kalaharigt.com/.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward-Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
Kalahari Greentech, Inc. Details the Wind Generator
FORT WALTON BEACH, Fla., June 18, 2010 (GLOBE NEWSWIRE) -- Kalahari Greentech, Inc. (Pink Sheets:KHGT - News) released a statement today discussing its cutting-edge Wind Generator system in detail.
Wind and solar are fast becoming the leading sources of renewable energy. Kalahari Greentech designs, produces and provides wind turbines, solar collectors and other sustainable energy technologies. Nearly $2 billion in money from the American Recovery and Reinvestment Act has been spent on wind power, funding the creation of enough new wind farms to power 2.4 million homes over the past year. (Source: http://www.abcnews.com/).
Kalahari's Wind Generator concentrates wind energy in a manner such that it can generate electric power at speeds usually too slow for conventional wind generators to produce any meaningful energy, or to even operate. It can also be modified to operate in water. For instance, it can be utilized in streams, rivers and tidal basins.
Many wind generators on the market today are a hazard to birds and other wildlife. Kalahari's Wind Generator avoids the bird strike problem because each unit comes standard with a shield that blocks birds from being hit by the turbine blades. The screen is sufficiently fine, such that not even a hummingbird can get through. The unit also releases short-range ultra-sonic waves that deter insects from nesting within the apparatus.
According to the American Wind Energy Association, the U.S. Department of Energy announced a goal of obtaining 6% of U.S. electricity from wind by 2020. From 1990 -- 2002, wind has been the fastest-growing power source worldwide on a percentage basis, with an annual average growth rate exceeding 30%. An average U.S. household uses about 10,655 kilowatt-hours of electricity each year. One megawatt of wind energy can generate 2.4 to more than 3 million kilowatt-hours per year. At the end of 2009, the installed capacity of wind power in the United States was just over 35,000 megawatts. Texas, with 9,410 MW of capacity, has the most installed wind power capacity of any U.S. state, followed by Iowa with 3,053 MW. (Source: http://www.awea.org/).
Research indicates that Kalahari's Wind Generators are cost effective when the energy they produce outweighs the cost of the unit. By installing at the point of greatest need, the units also eliminate the need to create an alternate energy power grid and suffer the transmission line losses.
More information can be found on the company's website, http://www.kalaharigt.com/.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
Wind and solar are fast becoming the leading sources of renewable energy. Kalahari Greentech designs, produces and provides wind turbines, solar collectors and other sustainable energy technologies. Nearly $2 billion in money from the American Recovery and Reinvestment Act has been spent on wind power, funding the creation of enough new wind farms to power 2.4 million homes over the past year. (Source: http://www.abcnews.com/).
Kalahari's Wind Generator concentrates wind energy in a manner such that it can generate electric power at speeds usually too slow for conventional wind generators to produce any meaningful energy, or to even operate. It can also be modified to operate in water. For instance, it can be utilized in streams, rivers and tidal basins.
Many wind generators on the market today are a hazard to birds and other wildlife. Kalahari's Wind Generator avoids the bird strike problem because each unit comes standard with a shield that blocks birds from being hit by the turbine blades. The screen is sufficiently fine, such that not even a hummingbird can get through. The unit also releases short-range ultra-sonic waves that deter insects from nesting within the apparatus.
According to the American Wind Energy Association, the U.S. Department of Energy announced a goal of obtaining 6% of U.S. electricity from wind by 2020. From 1990 -- 2002, wind has been the fastest-growing power source worldwide on a percentage basis, with an annual average growth rate exceeding 30%. An average U.S. household uses about 10,655 kilowatt-hours of electricity each year. One megawatt of wind energy can generate 2.4 to more than 3 million kilowatt-hours per year. At the end of 2009, the installed capacity of wind power in the United States was just over 35,000 megawatts. Texas, with 9,410 MW of capacity, has the most installed wind power capacity of any U.S. state, followed by Iowa with 3,053 MW. (Source: http://www.awea.org/).
Research indicates that Kalahari's Wind Generators are cost effective when the energy they produce outweighs the cost of the unit. By installing at the point of greatest need, the units also eliminate the need to create an alternate energy power grid and suffer the transmission line losses.
More information can be found on the company's website, http://www.kalaharigt.com/.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
Kendall Square Research Inc Announces Greater Than Expected First Quarter Results
LAS VEGAS, June 18 /PRNewswire-FirstCall/ -- Kendall Square Research, Inc. (Pink Sheets:KSQR.pk - News) announces that the 2010 first Quarter revenues and profits for their division Luxury Kitchen Hoods were significantly greater than expected and that the second quarter revenues and profits are also achieving the same accelerating results.
David Zisman, president of Luxury Kitchen Hoods said, "That if this trend continues the year end numbers would reflect a substantial profit for the Company".
About Kendall Square Research
Kendall Square Research, Inc (KSQR) is a Holding Company with targeted acquisitions in specialty equipment for residential home customers and green energy products. Luxury Kitchen Hoods LLC is the first acquisition and the flagship for the Company. A second acquisition is in process for a high energy city street light program with the capability of reducing the city lighting energy by 50%. Other acquisitions are in the planning stage.
For Additional Information, go to the Website: http://www.kitchenhood.com/
This press release contains certain "forward-looking statements" within the meaning of federal securities laws intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995, including the use of the words "expect," "anticipate," "estimate," "project," "forecast," "target," "objective," "goal," "plan" and similar expressions. There are certain business risks and uncertainties that could cause actual results to differ materially from those indicated by such forward-looking statements.
David Zisman, president of Luxury Kitchen Hoods said, "That if this trend continues the year end numbers would reflect a substantial profit for the Company".
About Kendall Square Research
Kendall Square Research, Inc (KSQR) is a Holding Company with targeted acquisitions in specialty equipment for residential home customers and green energy products. Luxury Kitchen Hoods LLC is the first acquisition and the flagship for the Company. A second acquisition is in process for a high energy city street light program with the capability of reducing the city lighting energy by 50%. Other acquisitions are in the planning stage.
For Additional Information, go to the Website: http://www.kitchenhood.com/
This press release contains certain "forward-looking statements" within the meaning of federal securities laws intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995, including the use of the words "expect," "anticipate," "estimate," "project," "forecast," "target," "objective," "goal," "plan" and similar expressions. There are certain business risks and uncertainties that could cause actual results to differ materially from those indicated by such forward-looking statements.
Friday, June 18, 2010
Kalahari Greentech, Inc. Announces New Wind & Solar Energy Technologies
FORT WALTON BEACH, Fla., June 17, 2010 (GLOBE NEWSWIRE) -- Kalahari Greentech, Inc. (Pink Sheets:KHGT - News) released a statement today introducing its cutting-edge wind and solar technologies. Nearly $2 billion in money from the American Recovery and Reinvestment Act has been spent on wind power, funding the creation of enough new wind farms to power 2.4 million homes over the past year. (Source: http://www.globenewswire.com/newsroom/ctr?d=194483&l=1&a=www.abcnews.com&u=http%3A%2F%2Fwww.abcnews.com).
Wind and solar are fast becoming the leading sources of renewable energy. Kalahari Greentech designs, produces and provides wind turbines, solar collectors and other sustainable energy technologies. Kalahari's Solar Collector is a three-part "tri-brid" system that increases the efficiency of solar collection in one cost-effective unit.
Kalahari's Wind Generator concentrates wind energy in a manner such that it can generate electric power at speeds usually too slow for conventional wind generators to produce any meaningful energy, or to even operate. It can also be modified to operate in water, and is safe for birds and wildlife.
According to the U.S. Department of Energy's news release dated March 25, 2009, entitled, "Solar Energy Grew at a Record Pace in 2008," solar energy deployment increased at a record pace in the United States and throughout the world in 2008. On March 19, 2009 the Solar Energy Industries Association (SEIA) released its "2008 U.S. Solar Industry Year in Review," which found that U.S. solar energy capacity increased by 17% the past year, reaching the equivalent of 8,775 megawatts (MW). The SEIA report also notes that the United States installed 342 MW of solar photovoltaic (PV) electric power, 139 thermal megawatts (MWTh) of solar water heating, 762 MWTh of pool heating, and 21 MWTh of solar space heating and cooling in 2008. (Source: http://www.energy.gov/).
According to the American Wind Energy Association, the U.S. Department of Energy announced a goal of obtaining 6% of U.S. electricity from wind by 2020. From 1990 -- 2002, wind has been the fastest-growing power source worldwide on a percentage basis, with an annual average growth rate exceeding 30%. An average U.S. household uses about 10,655 kilowatt-hours of electricity each year. One megawatt of wind energy can generate 2.4 to more than 3 million kilowatt-hours per year. At the end of 2009, the installed capacity of wind power in the United States was just over 35,000 megawatts. Texas, with 9,410 MW of capacity, has the most installed wind power capacity of any U.S. state, followed by Iowa with 3,053 MW. (Source: http://www.awea.org/).
More information can be found on the company's website, http://www.kalaharigt.com/.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
Wind and solar are fast becoming the leading sources of renewable energy. Kalahari Greentech designs, produces and provides wind turbines, solar collectors and other sustainable energy technologies. Kalahari's Solar Collector is a three-part "tri-brid" system that increases the efficiency of solar collection in one cost-effective unit.
Kalahari's Wind Generator concentrates wind energy in a manner such that it can generate electric power at speeds usually too slow for conventional wind generators to produce any meaningful energy, or to even operate. It can also be modified to operate in water, and is safe for birds and wildlife.
According to the U.S. Department of Energy's news release dated March 25, 2009, entitled, "Solar Energy Grew at a Record Pace in 2008," solar energy deployment increased at a record pace in the United States and throughout the world in 2008. On March 19, 2009 the Solar Energy Industries Association (SEIA) released its "2008 U.S. Solar Industry Year in Review," which found that U.S. solar energy capacity increased by 17% the past year, reaching the equivalent of 8,775 megawatts (MW). The SEIA report also notes that the United States installed 342 MW of solar photovoltaic (PV) electric power, 139 thermal megawatts (MWTh) of solar water heating, 762 MWTh of pool heating, and 21 MWTh of solar space heating and cooling in 2008. (Source: http://www.energy.gov/).
According to the American Wind Energy Association, the U.S. Department of Energy announced a goal of obtaining 6% of U.S. electricity from wind by 2020. From 1990 -- 2002, wind has been the fastest-growing power source worldwide on a percentage basis, with an annual average growth rate exceeding 30%. An average U.S. household uses about 10,655 kilowatt-hours of electricity each year. One megawatt of wind energy can generate 2.4 to more than 3 million kilowatt-hours per year. At the end of 2009, the installed capacity of wind power in the United States was just over 35,000 megawatts. Texas, with 9,410 MW of capacity, has the most installed wind power capacity of any U.S. state, followed by Iowa with 3,053 MW. (Source: http://www.awea.org/).
More information can be found on the company's website, http://www.kalaharigt.com/.
About Kalahari Greentech, Inc.: Kalahari Greentech Inc. is an energy company focused on developing, constructing and operating wind and solar energy projects, either on its own or in partnership with other energy companies. The company's main focus is to seek out opportunities to utilize its technology to develop renewable energy sources.
Forward Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.
Wednesday, June 16, 2010
Avalon Announces Results of First Phase of Workover in Lamar County, Mississippi
MINNEAPOLIS, May 26 /PRNewswire-FirstCall/ -- Avalon Oil & Gas, Inc., ("Avalon") (OTC Bulletin Board:AOGN.ob - News) announces it has completed the first phase of the workover of the Baxterville Field Prospect in Lamar County, Mississippi.. Avalon is purchasing an 18.75% working interest in the Baxterville Field Prospect from Bayside Petroleum Company, Inc. (Pink Sheets:BYSD.pk - News).The two hundred (200) acre leasehold contains three wellbores; two wells are equipped for production, and a salt water disposal well.
"We are excited to have completed the first phase of the workover of the Baxterville Field Prospect," said Avalon's CEO, Kent A. Rodriguez. "The salt water disposal well passed inspection. In addition a hot oil treatment to separate the oil and water in the three 200-barrel tanks was successful, and Plains Marketing completed a pick-up of oil. We plan to pull all existing downhole equipment, clean out the wellbore, run a gamma ray log, re-perforate the Upper Tuscaloosa zone, re-run tubing and test the flow rate for initial fluid entry rates on the Moody 31-9 #5, in the next few days," added Rodriguez.
The Baxterville Field spans over 13,000 acres, with more than 300 producing wells. The field has produced 262 million barrels of oil and 450 billion cubic feet of gas, primarily from the Tuscaloosa formation. The wellbores on the Baxterville Field Prospect have produced from the Lower Tuscaloosa Sand at a depth of 8,800 feet. The Tuscaloosa oil in this field has a very low gravity, around 17 API, and is produced with a large volume of salt water. The three wells have produced more than 500,000 barrels of oil and were producing 200 barrels of fluid, with a 5% oil cut, when they were shut-in in 2006.
About Avalon Oil & Gas, Inc. Avalon Oil & Gas is an oil and gas company engaged in the acquisition and development of producing oil and gas properties. In addition, Avalon's technology group acquires and develops energy production enhancing technologies. Through Oiltek, Inc., Avalon's majority-owned subsidiary, Avalon is building an asset portfolio of innovative technologies in the energy industry to maximize enhancement opportunities. To learn more about AOGN, please visit: http://www.avalonoil.com/.
About Bayside Petroleum Company, Inc. is an energy exploration, development and production company in the process of building oil & gas reserves and production in some of the most prolific hydrocarbon bearing regions of the United States. Specializing in the reworking of wells in oil and gas fields with proven reserves to enhance production, Bayside is well positioned to substantially increase its proven reserves, cash flow and shareholder value over the next 12 to 18 months. To learn more about BYSD, please visit: http://www.baysidepetroleum.com/.
Forward-Looking Statements
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Avalon Oil & Gas, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
"We are excited to have completed the first phase of the workover of the Baxterville Field Prospect," said Avalon's CEO, Kent A. Rodriguez. "The salt water disposal well passed inspection. In addition a hot oil treatment to separate the oil and water in the three 200-barrel tanks was successful, and Plains Marketing completed a pick-up of oil. We plan to pull all existing downhole equipment, clean out the wellbore, run a gamma ray log, re-perforate the Upper Tuscaloosa zone, re-run tubing and test the flow rate for initial fluid entry rates on the Moody 31-9 #5, in the next few days," added Rodriguez.
The Baxterville Field spans over 13,000 acres, with more than 300 producing wells. The field has produced 262 million barrels of oil and 450 billion cubic feet of gas, primarily from the Tuscaloosa formation. The wellbores on the Baxterville Field Prospect have produced from the Lower Tuscaloosa Sand at a depth of 8,800 feet. The Tuscaloosa oil in this field has a very low gravity, around 17 API, and is produced with a large volume of salt water. The three wells have produced more than 500,000 barrels of oil and were producing 200 barrels of fluid, with a 5% oil cut, when they were shut-in in 2006.
About Avalon Oil & Gas, Inc. Avalon Oil & Gas is an oil and gas company engaged in the acquisition and development of producing oil and gas properties. In addition, Avalon's technology group acquires and develops energy production enhancing technologies. Through Oiltek, Inc., Avalon's majority-owned subsidiary, Avalon is building an asset portfolio of innovative technologies in the energy industry to maximize enhancement opportunities. To learn more about AOGN, please visit: http://www.avalonoil.com/.
About Bayside Petroleum Company, Inc. is an energy exploration, development and production company in the process of building oil & gas reserves and production in some of the most prolific hydrocarbon bearing regions of the United States. Specializing in the reworking of wells in oil and gas fields with proven reserves to enhance production, Bayside is well positioned to substantially increase its proven reserves, cash flow and shareholder value over the next 12 to 18 months. To learn more about BYSD, please visit: http://www.baysidepetroleum.com/.
Forward-Looking Statements
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Avalon Oil & Gas, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
Monday, June 14, 2010
Ingen Unveils the New SMART Nasal Cannula at Alpha-1
YUCAIPA, Calif., June 14, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S. and $8 billion globally, unveiled their new SMART Nasal Cannula in Orlando-Florida last week at the Alpha-1 19th Annual National Education Conference.
The Alpha-1 Association is a member-based not-for-profit organization dedicated to identifying those affected by Alpha-1 Antitrypsin Deficiency (Alpha-1) and to improve the quality of their lives through support, education, advocacy and to encourage participation in research. Alpha-1-Antitrypsin Deficiency (Alpha-1) is a genetic disorder that can cause liver and lung disease in children and adults.
"We were very pleased to be an exhibitor and sponsor at this year's conference for Alpha-1. There are hundreds of patient members of the Alpha-1 Association, and many of them attended the conference, along with clinicians and physicians from around the globe. Our new SMART Nasal Cannula was featured and well accepted by the attendees. It is our goal to pick up the pace in supporting the various associations that support patients who require home oxygen therapy and the use of our products," stated Scott R. Sand, CEO and Chairman of the Board.
http://www.alpha1.org/education/nateduconf.php
http://www.ingen-tech.com/
http://www.smartnasalcannula.com/
http://www.ingenpulseoximeter.com/
About Ingen:
Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacturer representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
The Alpha-1 Association is a member-based not-for-profit organization dedicated to identifying those affected by Alpha-1 Antitrypsin Deficiency (Alpha-1) and to improve the quality of their lives through support, education, advocacy and to encourage participation in research. Alpha-1-Antitrypsin Deficiency (Alpha-1) is a genetic disorder that can cause liver and lung disease in children and adults.
"We were very pleased to be an exhibitor and sponsor at this year's conference for Alpha-1. There are hundreds of patient members of the Alpha-1 Association, and many of them attended the conference, along with clinicians and physicians from around the globe. Our new SMART Nasal Cannula was featured and well accepted by the attendees. It is our goal to pick up the pace in supporting the various associations that support patients who require home oxygen therapy and the use of our products," stated Scott R. Sand, CEO and Chairman of the Board.
http://www.alpha1.org/education/nateduconf.php
http://www.ingen-tech.com/
http://www.smartnasalcannula.com/
http://www.ingenpulseoximeter.com/
About Ingen:
Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacturer representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
Sunday, June 13, 2010
Company Update From the Chairman of Ingen Technologies
Gold Standard Set in Respiratory Market With Promising Fourth Quarter Results
YUCAIPA, Calif., June 11, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S. and $8 billion globally, today announced the following information updating shareholders on company progress:
During Ingen's fourth quarter the company focused aggressively on its marketing and advertising saturation campaign. This included being a featured product at the Las Vegas MedTrade Spring conference. The company has also published full color advertisements in major medical publications, such as COPD Digest, AARC Times, Everything Respiratory, LUNG Magazine, Today's Senior Magazine, and many others. Management is focused and dedicated to branding the company's product lines and increasing sales and distribution. Ingen is also scheduled for several major market conferences during the first quarter-2010, including Alpha-1 in Orlando, MedTrade in Georgia and AARC.
During the fourth quarter Ingen filed two more provisional patents; one for its new IngenThermo drug product, and the other for its new cannula technology. The IngenThermo uses polymer-crystal technology to keep insulin and other glass vile drugs cool and safe. Ingen's engineering team is working on the tooling and molds to manufacture this new product using medical-grade polycarbonate as an insulating material, along with polymer-crystals. We expect to deliver this product during the first quarter-2010. The new cannula technology involves the use of special materials that are embedded within the PVC of the nasal cannula. As oxygen flows, it will change the color of the cannula which would indicate a specific flow rate. This technology will complement Ingen's Oxyview technology and secure the company's position as maintaining the gold-standard within the respiratory oxygen therapy market.
The fourth quarter ended May 31, 2010 has proven to drive Ingen in the right direction with increased sales, increased assets and a decrease in debts. Specifically, sales were 80% higher in the fourth quarter as compared to the third quarter. Total sales for fourth quarter were approximately $10,000, as compared to $5,576 ending in the third quarter. The company was able to decrease the $4.5M note to its major note holders to $1.9M. It is expected that the company will fully reduce the balance of the notes over the first quarter of 2010. The company has a pending purchase order from a major distributor for $100,000 expected to ship in July with new inventory. Another expected purchase order from one of our OEM partners amounts to $120,000. Further, the company's government services consultant is expected to close $1.4M in government sales during the first and second quarters of 2010, while GSA evaluates the company's application submitted in September 2009. GSA usually takes 6-12 months to complete and approve applications. The company expects to reach its projected sales of $11M by end of our 2010 fiscal year. BSI (UK) is evaluating Ingen's CE Mark application, and we expect to achieve the CE Mark during our first quarter of 2010. The CE Mark and the ISO 13485:2003 certification allows the company to fulfill export orders for China, Canada, Australia and the European Communities. The People's Republic of China is also currently evaluating the company's ISO Registration, and it is expected that its products will reach the Chinese market by July 2010.
During our fourth quarter, Ingen secured a signed GPO contract with MediGroup Physician Services; one of the nation's largest GPO for the alternate site marketplace, which consists of specialty physicians and surgery centers. MediGroup provides its customers with the purchasing power that is traditionally reserved for hospitals, while enabling participating manufacturers and distributors to deliver products and services to a focused demographic. A Group Purchasing Organization (GPO) is an entity that helps health care providers - such as hospitals, nursing homes and home health agencies - realize cost-savings and efficiencies by aggregating purchasing volume and using that leverage to negotiate discounts with manufacturers, distributors and other vendors. There are more than 600 organizations in the United States that participate in some form of group purchasing. The company is negotiating several other GPO contracts to grow its sales in the hospital commercial market, and expects to see revenues from MediGroup during the first quarter-2010.
Ingen is at its reflex point and on the verge of tremendous growth, after enduring a number of regulatory and economic obstacles. In the face of economic headwinds, the company obtained both FDA and ISO Certification and launched several new and inspiring medical products in the respiratory market. As a result of this success, we have attracted many investors and new shareholders. The company's product line is essentially recession-proof and continues to gain momentum in the respiratory markets. Ingen has made important changes to foster a growth culture with a clear vision for the future. With these successes and changes, the company has undergone a restructuring in order to align their incentives with that of their shareholders. The company is now keenly focused on growth, open communication, and leadership by example, as it works diligently to expand its sales and deliver shareholder value.
Ingen has developed a global perspective on the markets in which it competes. First, the company conducted a thorough market study for our products with InTouch Life Science Corporation, while at the same time filing patents and trademarks for our proprietary technology; second, the company properly registered their products with the FDA and qualified the products for FDA export; third, the company hired Emergo Group, a recognized global consulting firm that assisted us with the ISO 13485 Certification, CE Mark and distribution partners in order to comply with the world markets for distribution of their medical products; and finally, the company hired KGMA Business Solutions, a leading consulting firm to prepare and file their GSA Contract, as well as develop government contracts with the VA Hospitals and Department of Defense. More important, Ingen has lowered their production costs for their products, increased their margins and the margins of their distributors, while keeping a competitive edge on pricing their products in today's challenging medical markets.
"I continue to believe that our inspiration comes from many sources - our shareholders, customers and consumers, as well as our critics. Our staff and consulting team have a passion for what they do that ignites this inspiration every day, everywhere we do business. We remain fresh, relevant and original by knowing what to change without changing what we know. We are asking more questions, listening more closely, and collaborating more effectively with our distribution partners and strategic consultants to give our customers the product they need, and provide our shareholders with the results that they deserve and expect," said Ingen CEO Scott Sand.
http://www.ingen-tech.com/
http://www.smartnasalcannula.com/
http://www.ingenpulseoximeter.com/
Ingen Technologies specializes in marketing, developing and distributing of medical technology products. Products designed by Ingen are providing effective and reliable solutions to medical professionals and patients worldwide while also enabling companies like Lincare Holdings (LNCR) and Cardinal Health, Inc. (CAH) the ability to meet a low cost minimization point which could help save the industry billions of dollars and improve patient quality of life -- a value proposition that is impossible to ignore for very long!
About Ingen:
Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacturer representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
YUCAIPA, Calif., June 11, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S. and $8 billion globally, today announced the following information updating shareholders on company progress:
During Ingen's fourth quarter the company focused aggressively on its marketing and advertising saturation campaign. This included being a featured product at the Las Vegas MedTrade Spring conference. The company has also published full color advertisements in major medical publications, such as COPD Digest, AARC Times, Everything Respiratory, LUNG Magazine, Today's Senior Magazine, and many others. Management is focused and dedicated to branding the company's product lines and increasing sales and distribution. Ingen is also scheduled for several major market conferences during the first quarter-2010, including Alpha-1 in Orlando, MedTrade in Georgia and AARC.
During the fourth quarter Ingen filed two more provisional patents; one for its new IngenThermo drug product, and the other for its new cannula technology. The IngenThermo uses polymer-crystal technology to keep insulin and other glass vile drugs cool and safe. Ingen's engineering team is working on the tooling and molds to manufacture this new product using medical-grade polycarbonate as an insulating material, along with polymer-crystals. We expect to deliver this product during the first quarter-2010. The new cannula technology involves the use of special materials that are embedded within the PVC of the nasal cannula. As oxygen flows, it will change the color of the cannula which would indicate a specific flow rate. This technology will complement Ingen's Oxyview technology and secure the company's position as maintaining the gold-standard within the respiratory oxygen therapy market.
The fourth quarter ended May 31, 2010 has proven to drive Ingen in the right direction with increased sales, increased assets and a decrease in debts. Specifically, sales were 80% higher in the fourth quarter as compared to the third quarter. Total sales for fourth quarter were approximately $10,000, as compared to $5,576 ending in the third quarter. The company was able to decrease the $4.5M note to its major note holders to $1.9M. It is expected that the company will fully reduce the balance of the notes over the first quarter of 2010. The company has a pending purchase order from a major distributor for $100,000 expected to ship in July with new inventory. Another expected purchase order from one of our OEM partners amounts to $120,000. Further, the company's government services consultant is expected to close $1.4M in government sales during the first and second quarters of 2010, while GSA evaluates the company's application submitted in September 2009. GSA usually takes 6-12 months to complete and approve applications. The company expects to reach its projected sales of $11M by end of our 2010 fiscal year. BSI (UK) is evaluating Ingen's CE Mark application, and we expect to achieve the CE Mark during our first quarter of 2010. The CE Mark and the ISO 13485:2003 certification allows the company to fulfill export orders for China, Canada, Australia and the European Communities. The People's Republic of China is also currently evaluating the company's ISO Registration, and it is expected that its products will reach the Chinese market by July 2010.
During our fourth quarter, Ingen secured a signed GPO contract with MediGroup Physician Services; one of the nation's largest GPO for the alternate site marketplace, which consists of specialty physicians and surgery centers. MediGroup provides its customers with the purchasing power that is traditionally reserved for hospitals, while enabling participating manufacturers and distributors to deliver products and services to a focused demographic. A Group Purchasing Organization (GPO) is an entity that helps health care providers - such as hospitals, nursing homes and home health agencies - realize cost-savings and efficiencies by aggregating purchasing volume and using that leverage to negotiate discounts with manufacturers, distributors and other vendors. There are more than 600 organizations in the United States that participate in some form of group purchasing. The company is negotiating several other GPO contracts to grow its sales in the hospital commercial market, and expects to see revenues from MediGroup during the first quarter-2010.
Ingen is at its reflex point and on the verge of tremendous growth, after enduring a number of regulatory and economic obstacles. In the face of economic headwinds, the company obtained both FDA and ISO Certification and launched several new and inspiring medical products in the respiratory market. As a result of this success, we have attracted many investors and new shareholders. The company's product line is essentially recession-proof and continues to gain momentum in the respiratory markets. Ingen has made important changes to foster a growth culture with a clear vision for the future. With these successes and changes, the company has undergone a restructuring in order to align their incentives with that of their shareholders. The company is now keenly focused on growth, open communication, and leadership by example, as it works diligently to expand its sales and deliver shareholder value.
Ingen has developed a global perspective on the markets in which it competes. First, the company conducted a thorough market study for our products with InTouch Life Science Corporation, while at the same time filing patents and trademarks for our proprietary technology; second, the company properly registered their products with the FDA and qualified the products for FDA export; third, the company hired Emergo Group, a recognized global consulting firm that assisted us with the ISO 13485 Certification, CE Mark and distribution partners in order to comply with the world markets for distribution of their medical products; and finally, the company hired KGMA Business Solutions, a leading consulting firm to prepare and file their GSA Contract, as well as develop government contracts with the VA Hospitals and Department of Defense. More important, Ingen has lowered their production costs for their products, increased their margins and the margins of their distributors, while keeping a competitive edge on pricing their products in today's challenging medical markets.
"I continue to believe that our inspiration comes from many sources - our shareholders, customers and consumers, as well as our critics. Our staff and consulting team have a passion for what they do that ignites this inspiration every day, everywhere we do business. We remain fresh, relevant and original by knowing what to change without changing what we know. We are asking more questions, listening more closely, and collaborating more effectively with our distribution partners and strategic consultants to give our customers the product they need, and provide our shareholders with the results that they deserve and expect," said Ingen CEO Scott Sand.
http://www.ingen-tech.com/
http://www.smartnasalcannula.com/
http://www.ingenpulseoximeter.com/
Ingen Technologies specializes in marketing, developing and distributing of medical technology products. Products designed by Ingen are providing effective and reliable solutions to medical professionals and patients worldwide while also enabling companies like Lincare Holdings (LNCR) and Cardinal Health, Inc. (CAH) the ability to meet a low cost minimization point which could help save the industry billions of dollars and improve patient quality of life -- a value proposition that is impossible to ignore for very long!
About Ingen:
Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacturer representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
Wednesday, June 9, 2010
Vivakor Expands Market for VivaSight Technologies to Adult Vision Care and Further Increases Revenue Outlook
CORALVILLE, Iowa, June 8, 2010 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTCBB:VIVK - News) announced new markets for its VivaSight technologies and further increased revenue projections for its VivaSight division. The new market mainly includes adult vision care to be used by Ophthalmologists and Optometrists. Speaking about this new development, Matt Nicosia, Vivakor's Chairman, said, "Adult vision care is a growing market with an aging population. Existing vision screening devices do not properly detect adult issues and our technology has the capability of addressing this need. VivaSight technology is useful mainly for children's screening but has the potential to be a very valuable asset in adult vision care. Our devices use cutting edge technology developed by our multidisciplinary research model to save time and money while enhancing exactness in all our detection efforts."
Additionally, VivaSight technologies will be marketed as the best and most versatile vision screening devices on the market. Mr. Matt Nicosia stated, "The market for vision screening is not just limited to United States vision care. We have received significant attention through our commercialization partners for international use of the VivaSight technology for both private practice and government mandated vision care." This announcement will expand upon Vivakor's recently released revenue projections for its VivaSight division and increase the estimated market to $50 million annually.
About Vivakor, Inc.
Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at http://www.vivakor.com/.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.
Additionally, VivaSight technologies will be marketed as the best and most versatile vision screening devices on the market. Mr. Matt Nicosia stated, "The market for vision screening is not just limited to United States vision care. We have received significant attention through our commercialization partners for international use of the VivaSight technology for both private practice and government mandated vision care." This announcement will expand upon Vivakor's recently released revenue projections for its VivaSight division and increase the estimated market to $50 million annually.
About Vivakor, Inc.
Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at http://www.vivakor.com/.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.
GeoBio Energy, Inc. Engages Experienced Accounting Firm to Update SEC Filings and Perform Audits of Proposed Acquisitions
SEATTLE, June 8, 2010 (GLOBE NEWSWIRE) -- GeoBio Energy, Inc. (Pink Sheets:GBOE - News) ("GeoBio"), is pleased to announce its engagement of Peterson Sullivan LLP to review the filings to bring GeoBio current and perform the audit of GeoBio's two previously announced acquisition targets in the natural gas and oil services industry.
Peterson Sullivan LLP, based in Seattle, is one of the largest CPA firms in the Pacific Northwest and has extensive experience and expertise with publicly traded companies, closely held businesses and nonprofits. The firm is registered with the Public Company Accounting Oversight Board and is an independent member firm associated TIAG and MSNA. Peterson Sullivan will review and audit the SEC filings in order to bring GeoBio current in its 1934 Exchange Act disclosure obligations, and perform the audits on the two target acquisitions.
The firm will perform their work under the direction of Douglas A. Daniel, GeoBio's incoming Senior Vice President of Corporate Development and Finance. "Both Doug and I are very happy to have an experienced and very qualified firm to bring the company current and complete the audits of our two proposed acquisitions," said GeoBio's incoming CEO, John Sams, "We look forward to moving forward with our business integration and planned growth strategy after timely completion of this work."
About GeoBio Energy:
GeoBio Energy's (http://www.GeoBioEnergyInc.com/) business model emphasizes the acquisition and operation of existing companies in the oil and gas services and energy industry. As oil well and gas exploration continue in the face of ever rising demand, preparing and monitoring drilling sites and obtaining peak efficiency and production from existing, aging wells becomes increasingly important. GeoBio believes this to be a significant growth opportunity in its strategy to combine and consolidate companies in the oil and natural gas services sector.
Media Services by: http://www.Smallcap1.com/ & http://www.MicroCap1.com/
Safe Harbor Statement
The contents of this Press Release may contain forward-looking statements which can be generally identified as such because the context of the statement will include the words such as GBOE "expects," "should," "believes," "intends," "anticipates" or words of similar import. Such forward-looking statements are subject to certain risks and uncertainties including the financial performance of GBOE, which could cause actual results, performance or achievements of GBOE to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements.
This Press Release does not constitute or form any part of any offer or invitation to sell or issue or any solicitation of any offer to purchase or subscribe for any securities in any jurisdiction, nor shall it (or any part of it) or the fact of its distribution form the basis of, or be relied upon in connection with, or act as any inducement to enter into, any contract or commitment therefore.
"Forward-looking statements," as defined in the Private Securities Litigation Reform Act of 1995, may be included in this press release. These statements relate to future events and/or our future financial performance. These statements are only predictions and may differ materially from actual future events or results. GBOE disclaims any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. Risks particularly associated with our current business include, but are not limited to the risks associated with our ability to (i) obtain the necessary financing to complete our prospective acquisitions of targeted companies and to finance our current operations, (ii) generate sufficient revenue and obtain profitability, (iii) obtain additional financing as needed, (iv) manage changes in general economic and business conditions (both generally and in the natural gas and oil services and the energy industry), (v) react to actions of our competitors, (vi) develop new services and markets for our services, (vii) identify and manage risks in connection with acquisitions (viii) evaluate the level of demand and market acceptance of our services and (ix) make necessary changes to our business strategies.
Peterson Sullivan LLP, based in Seattle, is one of the largest CPA firms in the Pacific Northwest and has extensive experience and expertise with publicly traded companies, closely held businesses and nonprofits. The firm is registered with the Public Company Accounting Oversight Board and is an independent member firm associated TIAG and MSNA. Peterson Sullivan will review and audit the SEC filings in order to bring GeoBio current in its 1934 Exchange Act disclosure obligations, and perform the audits on the two target acquisitions.
The firm will perform their work under the direction of Douglas A. Daniel, GeoBio's incoming Senior Vice President of Corporate Development and Finance. "Both Doug and I are very happy to have an experienced and very qualified firm to bring the company current and complete the audits of our two proposed acquisitions," said GeoBio's incoming CEO, John Sams, "We look forward to moving forward with our business integration and planned growth strategy after timely completion of this work."
About GeoBio Energy:
GeoBio Energy's (http://www.GeoBioEnergyInc.com/) business model emphasizes the acquisition and operation of existing companies in the oil and gas services and energy industry. As oil well and gas exploration continue in the face of ever rising demand, preparing and monitoring drilling sites and obtaining peak efficiency and production from existing, aging wells becomes increasingly important. GeoBio believes this to be a significant growth opportunity in its strategy to combine and consolidate companies in the oil and natural gas services sector.
Media Services by: http://www.Smallcap1.com/ & http://www.MicroCap1.com/
Safe Harbor Statement
The contents of this Press Release may contain forward-looking statements which can be generally identified as such because the context of the statement will include the words such as GBOE "expects," "should," "believes," "intends," "anticipates" or words of similar import. Such forward-looking statements are subject to certain risks and uncertainties including the financial performance of GBOE, which could cause actual results, performance or achievements of GBOE to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements.
This Press Release does not constitute or form any part of any offer or invitation to sell or issue or any solicitation of any offer to purchase or subscribe for any securities in any jurisdiction, nor shall it (or any part of it) or the fact of its distribution form the basis of, or be relied upon in connection with, or act as any inducement to enter into, any contract or commitment therefore.
"Forward-looking statements," as defined in the Private Securities Litigation Reform Act of 1995, may be included in this press release. These statements relate to future events and/or our future financial performance. These statements are only predictions and may differ materially from actual future events or results. GBOE disclaims any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. Risks particularly associated with our current business include, but are not limited to the risks associated with our ability to (i) obtain the necessary financing to complete our prospective acquisitions of targeted companies and to finance our current operations, (ii) generate sufficient revenue and obtain profitability, (iii) obtain additional financing as needed, (iv) manage changes in general economic and business conditions (both generally and in the natural gas and oil services and the energy industry), (v) react to actions of our competitors, (vi) develop new services and markets for our services, (vii) identify and manage risks in connection with acquisitions (viii) evaluate the level of demand and market acceptance of our services and (ix) make necessary changes to our business strategies.
Monday, June 7, 2010
Vivakor Extends Its Business Development Agreement With Baker Consulting
CORALVILLE, Iowa, June 7, 2010 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTCBB:VIVK - News) has extended its Business Development agreement with Baker Consulting out of Walnut Creek, California and its affiliate group, Kyouko Group, Inc. out of South Florida for an additional six months. Baker Consulting has made great strides in assisting the company with distribution agreements and research collaboration. Vivakor's Chairman Matt Nicosia stated recently, "Baker Consulting, with its vast experience in medical device commercialization and corporate finance, has been very instrumental in our Company's commercialization efforts and we are very pleased in the progress that has been made thus far and we look forward to creating great value for Vivakor shareholders through this relationship."
About Vivakor, Inc.
Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handing and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at http://www.vivakor.com/.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.
About Vivakor, Inc.
Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handing and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at http://www.vivakor.com/.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.
TrustCash Mobile Payments Solution iPhone Device Management Specifications Completed
ATLANTA, GA--(Marketwire - 06/07/10) - TrustCash Holdings, Inc. ("TrustCash" or the "Company") (Pinksheets:TCHH - News) confirms that it has implemented the device management specifications in its proprietary database for the Apple iPhone. Using the previously developed proprietary TrustCash JAVA device management web application, all versions and variations of the iPhone shall be fully supported as part of the mobile payments product strategy.
Needham analyst Charles Wolf delivered a range of (far into the) future sales projections for iPhone sales, predicting these will reach 142.5 million sales in 2019 from 37.2 million this year. These figures assume the global smart phone market grows from 170.2 million units in 2009 to 569.8 million in 2019, and that Apple's market share grows from 15% to 25%.
The design of the TrustCash Device Manager shall support all future versions of the iPhone globally with an automated real-time update process to any hardware, software and firmware upgrades done by Apple. Thus, the support of the TrustCash mobile payments platform for all iPhones in the market today and well into the future will be immediate as they roll out of the assembly factories.
The consensus of the TrustCash team is: "You can't escape the lure and the loyalty of the iPhone. Visit any place where people, not just tech-geeks communicate and congregate, and you'll find lots of iPhones. It could be a Microsoft conference or even a Google function -- the iPhone is omnipresent."
TAKE OUR ONLINE SURVEY
Tell us where you want to use TrustCash at:
http://www.trustcash.com/signup_consumer1.php.
ABOUT TRUSTCASH
The TrustCash™ platform delivers a sophisticated, comprehensive online payment processing system.
The TrustCash technology infrastructure provides merchants with open access, PCI compliant payment processing. TrustCash™ is an E-Commerce expert providing online businesses with payment solutions needed to be successful.
Cautionary Statement Regarding Forward-Looking Statements
A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological changes and uncertainties related to the development of TrustCash's business model. The actual results TrustCash may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.
Needham analyst Charles Wolf delivered a range of (far into the) future sales projections for iPhone sales, predicting these will reach 142.5 million sales in 2019 from 37.2 million this year. These figures assume the global smart phone market grows from 170.2 million units in 2009 to 569.8 million in 2019, and that Apple's market share grows from 15% to 25%.
The design of the TrustCash Device Manager shall support all future versions of the iPhone globally with an automated real-time update process to any hardware, software and firmware upgrades done by Apple. Thus, the support of the TrustCash mobile payments platform for all iPhones in the market today and well into the future will be immediate as they roll out of the assembly factories.
The consensus of the TrustCash team is: "You can't escape the lure and the loyalty of the iPhone. Visit any place where people, not just tech-geeks communicate and congregate, and you'll find lots of iPhones. It could be a Microsoft conference or even a Google function -- the iPhone is omnipresent."
TAKE OUR ONLINE SURVEY
Tell us where you want to use TrustCash at:
http://www.trustcash.com/signup_consumer1.php.
ABOUT TRUSTCASH
The TrustCash™ platform delivers a sophisticated, comprehensive online payment processing system.
The TrustCash technology infrastructure provides merchants with open access, PCI compliant payment processing. TrustCash™ is an E-Commerce expert providing online businesses with payment solutions needed to be successful.
Cautionary Statement Regarding Forward-Looking Statements
A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological changes and uncertainties related to the development of TrustCash's business model. The actual results TrustCash may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.
Sunday, June 6, 2010
IGNT Forges an Indelible Mark In the Medical World With Projected Revenues of $200 Million in the Oxygen Cannula Market
YUCAIPA, Calif., June 4, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News) the leading global medical device manufacturer of intelligent oxygen nasal cannulas focused on the $4 billion respiratory market, today announced that its innovative SMART Nasal Cannula with Oxyview technology are addressing unmet needs with an expected $200 million in revenues over the next 5 years.
Ingen has recently noticed a nice spike in sales from respiratory equipment manufacturers who require Ingen's gas flow meter technology for their own medical equipment.
Since 2007 when Ingen first introduced Oxyview to the world of COPD patients, the acceptance of the product has been impressive. There is no other product like Oxyview that provides the additional information that patients and clinicians rely upon. With approximately 23 million patients in the U.S. -- and an estimated 600 million patients worldwide -- who suffer from chronic obstructive pulmonary disease (COPD), Ingen stands to capture $200M in revenues over the next 5 years. Since an average COPD patient uses two to three nasal cannulas each month to prevent bacteria build-up within the device, creating a growing recurring demand for the cannula is an additional benefit to Ingen's bottom line.
View Fact Sheet: http://www.ingen-tech.com/PDFbin/FactSheet.pdf
Ingen's SMART Nasal Cannula is superior and very different than that of the conventional oxygen nasal cannulas on the market that now are commoditized products and mass produced overseas and offer patients very little peace-of-mind. As a result, it is not uncommon for home care providers to make frequent visits to oxygen patients concerned that oxygen is not flowing from the tank to the cannula, since there is no way to accurately verify it.
Ingen's one-of-a-kind, patented, high quality SMART Nasal Cannula solves this problem by confirming the flow of oxygen and proper equipment function at roughly the same cost as a traditional cannula. The result is lower costs for home care providers and greater peace-of-mind for in-home oxygen patients with respiratory diseases like COPD.
"Ingen's innovative oxygen cannulas are rapidly gaining traction due to their unique ability to lower costs for home care providers and provide peace-of-mind for oxygen patients," said Ingen CEO Scott Sand. "We have already booked more than $160,000 in revenues during the fourth quarter with $300,000 more in OEM orders backlogged, in addition to $1.4M in government contracts -- and we're just scratching the surface."
http://www.ingen-tech.com/
http://www.smartnasalcannula.com/
http://www.ingenpulseoximeter.com/
About Ingen:
Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
Ingen has recently noticed a nice spike in sales from respiratory equipment manufacturers who require Ingen's gas flow meter technology for their own medical equipment.
Since 2007 when Ingen first introduced Oxyview to the world of COPD patients, the acceptance of the product has been impressive. There is no other product like Oxyview that provides the additional information that patients and clinicians rely upon. With approximately 23 million patients in the U.S. -- and an estimated 600 million patients worldwide -- who suffer from chronic obstructive pulmonary disease (COPD), Ingen stands to capture $200M in revenues over the next 5 years. Since an average COPD patient uses two to three nasal cannulas each month to prevent bacteria build-up within the device, creating a growing recurring demand for the cannula is an additional benefit to Ingen's bottom line.
View Fact Sheet: http://www.ingen-tech.com/PDFbin/FactSheet.pdf
Ingen's SMART Nasal Cannula is superior and very different than that of the conventional oxygen nasal cannulas on the market that now are commoditized products and mass produced overseas and offer patients very little peace-of-mind. As a result, it is not uncommon for home care providers to make frequent visits to oxygen patients concerned that oxygen is not flowing from the tank to the cannula, since there is no way to accurately verify it.
Ingen's one-of-a-kind, patented, high quality SMART Nasal Cannula solves this problem by confirming the flow of oxygen and proper equipment function at roughly the same cost as a traditional cannula. The result is lower costs for home care providers and greater peace-of-mind for in-home oxygen patients with respiratory diseases like COPD.
"Ingen's innovative oxygen cannulas are rapidly gaining traction due to their unique ability to lower costs for home care providers and provide peace-of-mind for oxygen patients," said Ingen CEO Scott Sand. "We have already booked more than $160,000 in revenues during the fourth quarter with $300,000 more in OEM orders backlogged, in addition to $1.4M in government contracts -- and we're just scratching the surface."
http://www.ingen-tech.com/
http://www.smartnasalcannula.com/
http://www.ingenpulseoximeter.com/
About Ingen:
Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
Vivakor Announces Receipt of LOI for $600k Investment
CORALVILLE, Iowa, June 4, 2010 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTCBB:VIVK - News) today announced that the Company has received a letter of intent for an investment up to $600,000 from Excelsior Management. The terms of the transaction are for an investment in restricted common stock at $0.08 per share or shares registered in the current S-1 at the S-1 price of $0.23 per share.
Vivakor Chairman Matt Nicosia added this statement to the news: "This investment interest in Vivakor coincides with management's belief that the Company is currently undervalued and validates management's efforts to create value by reducing debt and increasing the viability of its technologies. We look forward to increasing the Company's value through pushing forward commercialization efforts for both VIVASLICES and VIVASIGHT."
About Vivakor, Inc.
Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at http://www.vivakor.com/.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.
Vivakor Chairman Matt Nicosia added this statement to the news: "This investment interest in Vivakor coincides with management's belief that the Company is currently undervalued and validates management's efforts to create value by reducing debt and increasing the viability of its technologies. We look forward to increasing the Company's value through pushing forward commercialization efforts for both VIVASLICES and VIVASIGHT."
About Vivakor, Inc.
Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at http://www.vivakor.com/.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.
Wednesday, June 2, 2010
.Abviva Details Patent Information for its Breast Cancer Risk Assessment Technology
SANTA BARBARA, Calif., May 21 /PRNewswire-FirstCall/ -- Abviva, Inc. (Pink Sheets:ABVV.pk - News), a biomedical company engaged in the development and commercialization of breast cancer related applications of Mammastatin, today provided further details about worldwide patent protection for its breast cancer risk assessment technology.
The Company previously announced that the Japanese Patent Office issued two patents on the core technology that may be used for therapeutic applications and in the Company's breast cancer risk assessment test, the Mammastatin Serum Assay (MSA). The patents are the most recent of 13 international and U.S. patents to issue to the University of Michigan for breast cancer diagnostic and therapeutic uses of Mammastatin.
The international patents detail methods of use and compositions of Mammastatin in therapeutic and diagnostic applications in the United States (7 patents), Australia (2 patents), Canada (1), Europe (1), and Japan (2). These patents have issued starting in the United States and Australia in 2002, and continuing through the two most recent patents issued this year in Japan.
"Based upon the patents, we believe that we will be able to aggressively penetrate the largest markets worldwide with confidence that our intellectual property is secure," said Barrett Evans, CEO of Abviva. "There are additional patents that have been filed and we are hopeful that we will be able to obtain even further protection of our intellectual property as the Company grows."
The MSA was initially developed at the University of Michigan Cancer Center and is licensed exclusively to Abviva by the University for scientific and commercial development as a blood test to assess women's health. In scientific correlation studies women who tested high with the MSA test showed to have lower risk of breast cancer than women who tested low. These findings align with results of the original research conducted at the University of Michigan Cancer Center that demonstrated Mammastatin was normally produced by breast epithelial cells in healthy women and was missing or reduced in transformed breast epithelial cells. In previous studies, an independent biostatistician calculated the overall accuracy of the MSA test to be 84-86%.
"This further solidifies the domestic and international intellectual property protection strategy we have implemented with the University of Michigan," continued Mr. Evans. "The issuance of this patent will be very important as we gain regulatory approval and market presence for the Mammastatin technology internationally. These newest patent grant notifications further expand our worldwide patent protection and marketability for MSA."
About Abviva
Abviva, Inc. is a biomedical company engaged in the innovation, development and commercialization of breast cancer related applications of Mammastatin, a growth inhibitory protein discovered at the University of Michigan Cancer Center that demonstrated anti-breast cancer properties. The discovery was developed into a simple breast cancer diagnostic blood test that demonstrated healthy women have high or normal levels of the protein and women with breast cancer have no detectable or very low levels of the protein. Abviva intends to commercialize the Mammastatin Serum Assay as a reference test through its wholly owned subsidiary laboratory under CLIA certification.
Statements in this press release that are not strictly historical facts are "forward-looking" statements (identified by the words "believe", "estimate", "project", "expect" or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the Company does not undertake any obligation to publicly update or revise any forward-looking statements.
http://www.abviva.com/
The Company previously announced that the Japanese Patent Office issued two patents on the core technology that may be used for therapeutic applications and in the Company's breast cancer risk assessment test, the Mammastatin Serum Assay (MSA). The patents are the most recent of 13 international and U.S. patents to issue to the University of Michigan for breast cancer diagnostic and therapeutic uses of Mammastatin.
The international patents detail methods of use and compositions of Mammastatin in therapeutic and diagnostic applications in the United States (7 patents), Australia (2 patents), Canada (1), Europe (1), and Japan (2). These patents have issued starting in the United States and Australia in 2002, and continuing through the two most recent patents issued this year in Japan.
"Based upon the patents, we believe that we will be able to aggressively penetrate the largest markets worldwide with confidence that our intellectual property is secure," said Barrett Evans, CEO of Abviva. "There are additional patents that have been filed and we are hopeful that we will be able to obtain even further protection of our intellectual property as the Company grows."
The MSA was initially developed at the University of Michigan Cancer Center and is licensed exclusively to Abviva by the University for scientific and commercial development as a blood test to assess women's health. In scientific correlation studies women who tested high with the MSA test showed to have lower risk of breast cancer than women who tested low. These findings align with results of the original research conducted at the University of Michigan Cancer Center that demonstrated Mammastatin was normally produced by breast epithelial cells in healthy women and was missing or reduced in transformed breast epithelial cells. In previous studies, an independent biostatistician calculated the overall accuracy of the MSA test to be 84-86%.
"This further solidifies the domestic and international intellectual property protection strategy we have implemented with the University of Michigan," continued Mr. Evans. "The issuance of this patent will be very important as we gain regulatory approval and market presence for the Mammastatin technology internationally. These newest patent grant notifications further expand our worldwide patent protection and marketability for MSA."
About Abviva
Abviva, Inc. is a biomedical company engaged in the innovation, development and commercialization of breast cancer related applications of Mammastatin, a growth inhibitory protein discovered at the University of Michigan Cancer Center that demonstrated anti-breast cancer properties. The discovery was developed into a simple breast cancer diagnostic blood test that demonstrated healthy women have high or normal levels of the protein and women with breast cancer have no detectable or very low levels of the protein. Abviva intends to commercialize the Mammastatin Serum Assay as a reference test through its wholly owned subsidiary laboratory under CLIA certification.
Statements in this press release that are not strictly historical facts are "forward-looking" statements (identified by the words "believe", "estimate", "project", "expect" or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the Company does not undertake any obligation to publicly update or revise any forward-looking statements.
http://www.abviva.com/
Tuesday, June 1, 2010
CCTR Schedules Exclusive Webcast to Update 2010 $100 Million Revenue Goal After Achieving 100% Revenue Growth to $15 Million in First Quarter
DALLAS, TX--(Marketwire - 06/01/10) - China Crescent Enterprises, Inc. (OTC.BB:CCTR - News) has scheduled a Webcast presentation for tomorrow, June 2nd, to present an update on its 2010 outlook and goal of reaching $100 million in 2010 annual revenue, following the Company's record first quarter financial performance. China Crescent reported a more than 100% increase in first quarter revenue to nearly $15 million compared to the same period in 2009. Notably, net income increased more than 480% to approximately $657,000 versus the same period in 2009. A link to the Webcast will be posted to the corporate website, http://www.chinacrescent.com/, upon release.
Sign Up to Receive Regular China Crescent Investor Updates
China Crescent sends regular email updates to its opt-in, permission-based email database. Interested investors can easily, safely and quickly register to receive these communications directly on the corporate website homepage (http://www.chinacrescent.com/). Recipients can manage their own email contact profile and safely unsubscribe at any time.
About China Crescent Enterprises, Inc. (www.chinacrescent.com)
China Crescent is a systems integration service provider that markets technology outsourcing services in China including the sale and service of brand name technologies such as Microsoft, Oracle, Cisco, IBM, HP and Dell. Following a strategic acquisition last year, the Company expanded its business line to include original design manufacturing (ODM). China Crescent reported $45 million in profitable revenue in 2009 after reporting over $40 million in revenue for both 2007 and 2008 and has set a goal of reaching $100 million in revenue in 2010.
Headquartered in Dallas with operations in Shanghai, Shenzhen, Dalian and Beijing, China Crescent bridges the gap between global business cultures to assist clients worldwide realize the advantages of the high quality, low cost technology products and services available from China. China Crescent also assists clients in localizing products and services to realize the tremendous growth potential available by expanding into the Chinese Market.
"SAFE HARBOR STATEMENT" UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause China Crescent's actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.
Sign Up to Receive Regular China Crescent Investor Updates
China Crescent sends regular email updates to its opt-in, permission-based email database. Interested investors can easily, safely and quickly register to receive these communications directly on the corporate website homepage (http://www.chinacrescent.com/). Recipients can manage their own email contact profile and safely unsubscribe at any time.
About China Crescent Enterprises, Inc. (www.chinacrescent.com)
China Crescent is a systems integration service provider that markets technology outsourcing services in China including the sale and service of brand name technologies such as Microsoft, Oracle, Cisco, IBM, HP and Dell. Following a strategic acquisition last year, the Company expanded its business line to include original design manufacturing (ODM). China Crescent reported $45 million in profitable revenue in 2009 after reporting over $40 million in revenue for both 2007 and 2008 and has set a goal of reaching $100 million in revenue in 2010.
Headquartered in Dallas with operations in Shanghai, Shenzhen, Dalian and Beijing, China Crescent bridges the gap between global business cultures to assist clients worldwide realize the advantages of the high quality, low cost technology products and services available from China. China Crescent also assists clients in localizing products and services to realize the tremendous growth potential available by expanding into the Chinese Market.
"SAFE HARBOR STATEMENT" UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause China Crescent's actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.
Silver America, Inc. to Initiate Second Exploration Phase of High-Grade Silver Guadalupe Property
RENO, NV--(Marketwire - 06/01/10) - Silver America, Inc. (OTC.BB:SILA - News) ("Silver America" and/or "the Company") is pleased to report that the Board of Directors has approved the commencement of the second phase of its strategic field program at the Company's 698.91-acre Guadalupe Property in Zacatecas State, Mexico.
Upon review of the encouraging results announced in our press release dated May 13, 2010, which included bonanza grade silver grades of up to 1,800 g/t and gold grades of up to 5.35 g/t, the company has decided to proceed with the second phase of exploration at the Guadalupe Property. This next phase, which is expected to last 4 to 6 weeks, will consist of geophysics and soil sampling, with approximately 10.6 miles (17 kms) of magnetic and induced polarization surveys, as well as further detailed sampling and mapping of the entire area and workings.
The values encountered on the first phase of exploration, combined with the known depth of the historical workings (350 meters), suggest that these vein systems have the potential to continue to much greater depths, as is the case at the Fresnillo mine (900 vertical meters), the world's richest underground silver mine, located roughly 5 miles to the south of Silver America's property.
"Through this new phase of exploration, we expect to be able to delineate drilling targets for what we anticipate to be a 2,000-meter drilling campaign," said Johannes Petersen, President of Silver America. "Once we complete this phase of exploration, we intend to test the continuation of the known vein systems at depths greater than those of the historic workings, while exploring further any new structures we might identify with the geophysics work."
THE GUADALUPE PROPERTY
The Guadalupe property contains two historically significant mines and is located in one of Mexico's oldest mining districts, roughly 5 miles north of the Fresnillo (Proaño) Mine, the world's richest underground silver mine, operated by Fresnillo plc. Roughly 6.8 miles to the southwest of Silver America's Guadalupe Property is the Juanicipio Joint Venture (JV) between MAG Silver Corp. (MAG) and Fresnillo plc, which is known as one of the world's highest grade undeveloped silver resources.
ABOUT SILVER AMERICA, INC.
Silver America, Inc. is a publicly traded (OTC.BB:SILA - News) precious metals exploration company focused on the aggressive, ongoing acquisition and exploration of holdings with rich silver and gold production potential. Based in Reno, Nevada, Silver America has developed a promising portfolio of international properties in regions marked by stable politics, sound economies and friendly business relations. For more information on the Company and its projects, visit Silver America's website at http://www.silver-america.com/.
ON BEHALF OF THE BOARD OF DIRECTORS,
Johannes Petersen, President
Forward-Looking Statements
The statements by our officers, and other statements regarding optimism related to the business, expanding exploration and development activities and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many risk factors that affect the industry the Company operates in and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Upon review of the encouraging results announced in our press release dated May 13, 2010, which included bonanza grade silver grades of up to 1,800 g/t and gold grades of up to 5.35 g/t, the company has decided to proceed with the second phase of exploration at the Guadalupe Property. This next phase, which is expected to last 4 to 6 weeks, will consist of geophysics and soil sampling, with approximately 10.6 miles (17 kms) of magnetic and induced polarization surveys, as well as further detailed sampling and mapping of the entire area and workings.
The values encountered on the first phase of exploration, combined with the known depth of the historical workings (350 meters), suggest that these vein systems have the potential to continue to much greater depths, as is the case at the Fresnillo mine (900 vertical meters), the world's richest underground silver mine, located roughly 5 miles to the south of Silver America's property.
"Through this new phase of exploration, we expect to be able to delineate drilling targets for what we anticipate to be a 2,000-meter drilling campaign," said Johannes Petersen, President of Silver America. "Once we complete this phase of exploration, we intend to test the continuation of the known vein systems at depths greater than those of the historic workings, while exploring further any new structures we might identify with the geophysics work."
THE GUADALUPE PROPERTY
The Guadalupe property contains two historically significant mines and is located in one of Mexico's oldest mining districts, roughly 5 miles north of the Fresnillo (Proaño) Mine, the world's richest underground silver mine, operated by Fresnillo plc. Roughly 6.8 miles to the southwest of Silver America's Guadalupe Property is the Juanicipio Joint Venture (JV) between MAG Silver Corp. (MAG) and Fresnillo plc, which is known as one of the world's highest grade undeveloped silver resources.
ABOUT SILVER AMERICA, INC.
Silver America, Inc. is a publicly traded (OTC.BB:SILA - News) precious metals exploration company focused on the aggressive, ongoing acquisition and exploration of holdings with rich silver and gold production potential. Based in Reno, Nevada, Silver America has developed a promising portfolio of international properties in regions marked by stable politics, sound economies and friendly business relations. For more information on the Company and its projects, visit Silver America's website at http://www.silver-america.com/.
ON BEHALF OF THE BOARD OF DIRECTORS,
Johannes Petersen, President
Forward-Looking Statements
The statements by our officers, and other statements regarding optimism related to the business, expanding exploration and development activities and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many risk factors that affect the industry the Company operates in and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Subscribe to:
Posts (Atom)